PB2294: DOSE-ADJUSTED EDOCH AS FIRST-LINE THERAPY IMPROVED PROGNOSIS OF ADULT T-CELL LEUKEMIA/LYMPHOMA: A 11-YEAR MULTICENTER RETROSPECTIVE STUDY IN CHINA

• Luting Luo,
• Jiazheng LI,
• Wanying Liu,
• Yanxin Chen,
• Zhengjun Wu,
• Chengjun Nie,
• Xiaoyun Zheng,
• Renli Chen,
• Ting Yang,
• Jianda Hu

Affiliations

Luting Luo

1 Fujian Medical University Union Hospital, Fuzhou, China

Jiazheng LI

1 Fujian Medical University Union Hospital, Fuzhou, China

Wanying Liu

1 Fujian Medical University Union Hospital, Fuzhou, China

Yanxin Chen

1 Fujian Medical University Union Hospital, Fuzhou, China

Zhengjun Wu

1 Fujian Medical University Union Hospital, Fuzhou, China

Chengjun Nie

2 Ningde Hospital Affiliated to Ningde Normal University, Ningde, China

Xiaoyun Zheng

1 Fujian Medical University Union Hospital, Fuzhou, China

Renli Chen

2 Ningde Hospital Affiliated to Ningde Normal University, Ningde, China

Ting Yang

3 The First Affiliated Hospital of Fujian Medical University, Fuzhou, China

Jianda Hu

1 Fujian Medical University Union Hospital, Fuzhou, China